ENDRA Life Sciences (NDRA) Competitors

ENDRA Life Sciences logo
$5.26 -0.14 (-2.59%)
Closing price 02/7/2025 03:59 PM Eastern
Extended Trading
$5.49 +0.23 (+4.37%)
As of 02/7/2025 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NDRA vs. IINN, ICU, BTCY, AEMD, POAI, NURO, CUTR, MHUA, INBS, and PSTV

Should you be buying ENDRA Life Sciences stock or one of its competitors? The main competitors of ENDRA Life Sciences include Inspira Technologies Oxy B.H.N. (IINN), SeaStar Medical (ICU), Biotricity (BTCY), Aethlon Medical (AEMD), Predictive Oncology (POAI), NeuroMetrix (NURO), Cutera (CUTR), Meihua International Medical Technologies (MHUA), Intelligent Bio Solutions (INBS), and Plus Therapeutics (PSTV). These companies are all part of the "medical equipment" industry.

ENDRA Life Sciences vs.

ENDRA Life Sciences (NASDAQ:NDRA) and Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, valuation and dividends.

Inspira Technologies Oxy B.H.N.'s return on equity of 0.00% beat ENDRA Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
ENDRA Life SciencesN/A -127.39% -103.77%
Inspira Technologies Oxy B.H.N. N/A N/A N/A

ENDRA Life Sciences currently has a consensus price target of $700,000.00, suggesting a potential upside of 13,307,884.79%. Given ENDRA Life Sciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe ENDRA Life Sciences is more favorable than Inspira Technologies Oxy B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ENDRA Life Sciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Inspira Technologies Oxy B.H.N.
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

1.2% of ENDRA Life Sciences shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies Oxy B.H.N. shares are owned by institutional investors. 0.0% of ENDRA Life Sciences shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies Oxy B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Inspira Technologies Oxy B.H.N. had 2 more articles in the media than ENDRA Life Sciences. MarketBeat recorded 2 mentions for Inspira Technologies Oxy B.H.N. and 0 mentions for ENDRA Life Sciences. ENDRA Life Sciences' average media sentiment score of 0.00 equaled Inspira Technologies Oxy B.H.N.'saverage media sentiment score.

Company Overall Sentiment
ENDRA Life Sciences Neutral
Inspira Technologies Oxy B.H.N. Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ENDRA Life SciencesN/AN/A-$10.06M-$901.15-0.01
Inspira Technologies Oxy B.H.N.N/AN/A-$11.29MN/AN/A

ENDRA Life Sciences has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, Inspira Technologies Oxy B.H.N. has a beta of 2.1, suggesting that its share price is 110% more volatile than the S&P 500.

ENDRA Life Sciences received 233 more outperform votes than Inspira Technologies Oxy B.H.N. when rated by MarketBeat users. However, 100.00% of users gave Inspira Technologies Oxy B.H.N. an outperform vote while only 62.77% of users gave ENDRA Life Sciences an outperform vote.

CompanyUnderperformOutperform
ENDRA Life SciencesOutperform Votes
236
62.77%
Underperform Votes
140
37.23%
Inspira Technologies Oxy B.H.N.Outperform Votes
3
100.00%
Underperform Votes
No Votes

Summary

Inspira Technologies Oxy B.H.N. beats ENDRA Life Sciences on 7 of the 12 factors compared between the two stocks.

Get ENDRA Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NDRA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NDRA vs. The Competition

MetricENDRA Life SciencesElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.90M$3.44B$5.76B$9.10B
Dividend YieldN/A1.60%5.30%4.00%
P/E RatioN/A14.3765.0316.45
Price / SalesN/A62.24981.0964.65
Price / CashN/A44.0546.1438.79
Price / Book0.003.945.134.75
Net Income-$10.06M$90.91M$113.83M$222.45M
7 Day Performance4.08%-0.75%-0.42%0.16%
1 Month Performance-12.33%2.69%2.14%0.76%
1 Year Performance-99.99%18.34%22.22%19.97%

ENDRA Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NDRA
ENDRA Life Sciences
2.4262 of 5 stars
$5.26
-2.6%
$700,000.00
+13,307,884.8%
-100.0%$2.84MN/A-0.0120
IINN
Inspira Technologies Oxy B.H.N.
0.1118 of 5 stars
$0.85
-0.1%
N/A-0.8%$10.71MN/A0.0020Gap Up
ICU
SeaStar Medical
0.057 of 5 stars
$2.28
+1.8%
N/A-90.9%$10.17MN/A-0.202Gap Up
High Trading Volume
BTCY
Biotricity
N/A$0.39
+1.5%
N/A-50.0%$9.69M$12.06M-0.2940
AEMD
Aethlon Medical
1.7909 of 5 stars
$0.67
-4.5%
$7.00
+947.7%
-58.6%$9.33M$570,000.00-0.2410Upcoming Earnings
POAI
Predictive Oncology
1.2586 of 5 stars
$1.39
-5.4%
$3.00
+115.8%
-50.5%$9.27M$1.78M-0.4630Gap Down
NURO
NeuroMetrix
0.114 of 5 stars
$4.32
+0.2%
N/A+35.3%$8.81M$5.90M-0.9420Analyst Forecast
CUTR
Cutera
1.9277 of 5 stars
$0.43
0.0%
$3.00
+602.4%
-83.3%$8.62M$212.37M-0.06460Gap Up
MHUA
Meihua International Medical Technologies
0.3471 of 5 stars
$0.32
+0.5%
N/A-66.8%$8.03M$97.10M0.00620
INBS
Intelligent Bio Solutions
1.5296 of 5 stars
$1.75
-0.6%
N/A-68.7%$7.68M$3.11M0.0010Upcoming Earnings
High Trading Volume
PSTV
Plus Therapeutics
2.7671 of 5 stars
$1.24
+0.1%
$13.50
+987.3%
-37.2%$7.33M$4.91M-0.4920Gap Down

Related Companies and Tools


This page (NASDAQ:NDRA) was last updated on 2/10/2025 by MarketBeat.com Staff
From Our Partners